Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.

Saved in:
Bibliographic Details
Title: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.
Authors: Gupta S; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Glezerman IG; Renal Service, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College, New York, New York., Hirsch JS; Northwell Health, New Hyde Park, New York.; Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.; Clinical Digital Solutions, Northwell Health, Lake Success, New York., Chewcharat A; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Wells SL; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Ortega JL; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Pirovano M; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim R; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Chen KL; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Jhaveri KD; Northwell Health, New Hyde Park, New York.; Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York., Page VD; Division of Internal Medicine, Section of Nephrology, University of Texas MD Anderson Cancer Center, Houston., Abramson MH; Renal Service, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Bansal A; Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus Aurora, Aurora., Ghimire A; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora., Joy MS; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora., Abudayyeh A; Division of Internal Medicine, Section of Nephrology, University of Texas MD Anderson Cancer Center, Houston., Leaf DE; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Source: JAMA oncology [JAMA Oncol] 2025 Jun 01; Vol. 11 (6), pp. 636-643.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2025.0756